| 1. |
|
|
| 2. |
- Harms-Ringdahl, K, et al.
(författare)
-
Assessment of jet pilots' upper trapezius load calibrated to maximal voluntary contraction and a standardized load.
- 1996
-
Ingår i: Journal of Electromyography & Kinesiology. - : Elsevier BV. - 1050-6411 .- 1873-5711. ; 6:1, s. 67-72
-
Tidskriftsartikel (refereegranskat)abstract
- Electromyographic (EMG) recording of the myoelectrical activity level in the trapezius muscle is often used as one method of assessing neck and shoulder muscle workload. To analyse how the normalization value influences interpretation of upper trapezius load during a work task, two different reference values for normalization were applied - one obtained during a maximum voluntary contraction (MVE) and the other during a standardized muscular load (RVE). Nine jet pilots (ages 30-48 yr) flew two sorties in a 37 Viggen aircraft using either of two types of head garment while 3-D acceleration and muscular activity were recorded. In each sortie twice in the programme a steep left turn at 5-6 +G(Z) was performed. The highest activity level (MVE) obtained during shoulder elevation combined with an isometric heavy resistance (maximum) against arm flexion/abduction was used as one normalization value. Before, between, and after the two flights, 15 s EMG recordings (RVE) during a dumbbell test in the same arm position were also taken. The muscular activity in the upper trapezius during a given task varied a great deal between individuals, but the reliability of the amplitude levels on different occasions during a work day was good, given the same electrode location and application. If muscular activity during a standardized loading force (e.g. dumbbell test) is used to normalize the recordings for workload assessments related to utilized muscular capacity, a subject with high muscular strength and comparatively low workload might in some situations be assessed as having the same workload as, or a higher load than a subject with less strength and a comparatively high workload. While normalization using a standardized force can be used to assess changes in workload, for assessing workload related to the individual's capacity recording the myoelectrical activity during maximal contraction is preferable.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Ekholm, S, et al.
(författare)
-
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system
- 1996
-
Ingår i: Acta Radiologica. - 1600-0455. ; 37:2, s. 223-228
-
Tidskriftsartikel (refereegranskat)abstract
- PURPOSE: This Swedish multicenter trial was performed on patients with known or suspected lesions of the CNS for which an MR examination using a contrast medium was indicated. A total of 8 MR centers participated in the study to establish the safety and efficacy of Omniscan (gadodiamide injection) in clinical routine using a standard dose of 0.1 mmol Gd/kg b.w. MATERIAL AND METHODS: Seven hundred adult patients who had been referred for MR investigation of suspected CNS lesions were included in the study. Since most patients were examined on an outpatient basis, it was decided to use an explicit questionnaire regarding adverse events that developed within 24 h after examination. The efficacy evaluation involved comparisons of detectability, delineation, and number of lesions before and after injection of Omniscan. RESULTS: No serious or unexpected adverse event was found. There were a total of 70 (10.2%) patients with adverse events, excluding those judged not to be contrast media-related. However, only 15 patients (2.2%) had adverse events that possibly or probably were related to the contrast medium. Usually, the symptoms were headache, dizziness, abnormal taste, and nausea. Two patients complained of itching, but only one developed urticaria. The efficacy was similar to that of other currently used Gd-based MR agents. Lesions were more often seen on T2-weighted images, but the contrast medium improved lesion delineation, contributing to higher certainty in diagnosis, and provided more confidence in excluding suspected abnormality. CONCLUSION: Omniscan was found to be a safe and clinically valuable contrast medium for MR imaging of the CNS.
|
|
| 9. |
|
|
| 10. |
|
|
